Perceptions, Attitudes, and Barriers to Obesity Care in Mexico: Data From the ACTION-IO Study

Verónica Vázquez-Velázquez, Hugo Laviada-Molina, Eduardo García-García, Edurne Sandoval-Diez, Leonardo Mancillas-Adame, Verónica Vázquez-Velázquez, Hugo Laviada-Molina, Eduardo García-García, Edurne Sandoval-Diez, Leonardo Mancillas-Adame

Abstract

Objective: The Awareness, Care, and Treatment in Obesity Management-International Observation (ACTION-IO) study (ClinicalTrials.gov identifier NCT03584191) aimed to identify perceptions, attitudes, behaviors, and barriers to effective obesity care in people with obesity (PwO) and health care professionals (HCPs). This study presents the results from Mexico.

Methods: An online survey was conducted. In Mexico, eligible PwO were ≥18 years of age with BMI ≥30 kg/m2 based on self-reported height and weight. Eligible HCPs had direct patient care.

Results: The survey was completed by 2,000 PwO and 400 HCPs in Mexico. Many PwO (71%) and HCPs (94%) categorized obesity as a chronic disease. Sixty-three percent of PwO felt motivated to lose weight, but many HCPs perceived that PwO were not interested in losing weight (76%) or motivated to lose weight (69%). Lack of financial means to support weight-loss efforts was a barrier for PwO (34%) to discussing weight with HCPs. Sixty-five percent of PwO had discussed weight with HCPs in the past 5 years. PwO (80%) and HCPs (89%) considered lack of exercise as the main barrier to weight loss. Few PwO (34%) had successfully lost ≥5% of their body mass over the past 3 years.

Conclusions: This ACTION-IO study in Mexico identified discrepancies in the perceptions of PwO and HCPs, highlighting opportunities for further education and patient-centered approaches.

Conflict of interest statement

VV‐V reports personal fees and nonfinancial support from Novo Nordisk. ES‐D is an employee of Novo Nordisk A/S. HL‐M, EG‐G, and LM‐A have nothing to disclose.

© 2021 The Authors. Obesity published by Wiley Periodicals LLC on behalf of The Obesity Society (TOS).

Figures

Figure 1
Figure 1
Agreement of people with obesity (PwO) and health care professionals (HCPs) in Mexico with statements describing attitudes toward obesity. Agreement was rated on a scale of 1 (do not agree at all) to 5 (completely agree). Q, question.
Figure 2
Figure 2
Weight‐loss efforts and weight‐loss response in Mexico. (A) Past serious weight‐loss attempts by people with obesity (PwO); the percentage of patients considered by their health care professional (HCP) to have (B) made a serious attempt at weight loss and to have (C) been successful within the past year; and the (D) proportion of PwO who had 5% weight loss and maintenance of 5% weight loss in the past 3 years. S, screening question; Q, question.
Figure 3
Figure 3
Weight‐management discussions between people with obesity (PwO) and health care professionals (HCPs) and outcomes in Mexico. (A) Proportion of PwO who discussed weight management with an HCP, received an obesity diagnosis, and received a follow‐up appointment/call. (B) Time between the start of weight issues and discussions with an HCP for PwO who had discussed their weight with an HCP in the past 5 years. (C) Proportion of PwO who preferred their HCP to raise a weight issue during appointments. (D) Emotional impact on PwO after a weight‐management discussion with an HCP. Q, question.
Figure 4
Figure 4
Reasons for not holding discussions around weight with a health care professional (HCP) or patient for people with obesity (PwO) and HCPs in Mexico. Q, question.
Figure 5
Figure 5
Weight‐management methods deemed effective by people with obesity (PwO) and health care professionals (HCPs) in Mexico. For PwO, responses were only taken from those who had tried each method. Q, question.

References

    1. Bray GA, Frühbeck G, Ryan DH, Wilding JPH. Management of obesity. Lancet 2016;387:1947‐1956.
    1. Ghanemi A, Yoshioka M, St‐Amand J. Broken energy homeostasis and obesity pathogenesis: the surrounding concepts. J Clin Med 2018;7:453.
    1. Health at a Glance 2019: OECD Indicators . Organisation for Economic Co‐operation and Development. Updated November 7, 2019. Accessed June 8, 2020.
    1. Secretaría de Salud . Encuesta Nacional de Salud y Nutrición de Medio Camino 2016: Informe Final de Resultados. Instituto Nacional de Salud Pública; 2016.
    1. Bray GA, Kim KK, Wilding JPH; World Obesity Federation . Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev 2017;18:715‐723.
    1. Kassir R. Risk of COVID‐19 for patients with obesity. Obes Rev 2020;21:e13034. doi:10.1111/obr.13034
    1. Fernandez MA, Raine KD. Insights on the Influence of sugar taxes on obesity prevention efforts. Curr Nutr Rep 2019;8:333‐339.
    1. Secretaría de Gobernación . Norma Oficial Mexicana NOM‐008‐SSA3–2017, Para el Tratamiento Integral del Sobrepeso y la Obesidad In: Diario Oficial de la Federación. Secretaría de Gobernación; 2018. Accessed June 20, 2020.
    1. Díaz‐Zavala RG, Candia‐Plata MDC, Martínez‐Contreras TJ, Esparza‐Romero J. Lifestyle intervention for obesity: a call to transform the clinical care delivery system in Mexico. Diabetes Metab Syndr Obes 2019;12:1841‐1859.
    1. Aguilar Salinas C, Sevilla‐González M. Atención primaria. Modelo de control y atención a la salud In: Rivera‐Dommarco JA, Colchero MA, Fuentes ML, et al. eds. La obesidad en México Estado de la política pública y recomendaciones para su prevención y control. Mexico: Instituto Nacional De Salud Pública; 2018: 255.
    1. Herrera MF, Valencia A, Cohen R. Bariatric/metabolic surgery in Latin America. Am J Gastroenterol 2019;114:852‐853.
    1. Jannah N, Hild J, Gallagher C, Dietz W. Coverage for obesity prevention and treatment services: analysis of Medicaid and state employee health insurance programs. Obesity (Silver Spring) 2018;26:1834‐1840.
    1. Kyle TK, Dhurandhar EJ, Allison DB. Regarding obesity as a disease: evolving policies and their implications. Endocrinol Metab Clin North Am 2016;45:511‐520.
    1. Kaplan LM, Golden A, Jinnett K, et al. Perceptions of barriers to effective obesity care: results from the national ACTION study. Obesity (Silver Spring) 2018;26:61‐69.
    1. Sharma AM, Bélanger A, Carson V, et al. Perceptions of barriers to effective obesity management in Canada: results from the ACTION study. Clin Obes 2019;9:e12329. doi:10.1111/cob.12329
    1. Caterson ID, Alfadda AA, Auerbach P, et al. Gaps to bridge: misalignment between perception, reality and actions in obesity. Diabetes Obes Metab 2019;21:1914‐1924.
    1. Guidelines for Good Pharmacoepidemiology Practices (GPP) . International Society for Pharmacoepidemiology (ISPE). Updated June 2015. Accessed June 8, 2020.
    1. World Medical Association . World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191‐2194.
    1. Barquera S, White M. Treating obesity seriously in Mexico: realizing, much too late, action must be immediate. Obesity (Silver Spring) 2018;26:1530‐1531.
    1. Sbraccia P, Busetto L, Santini F, Mancuso M, Nicoziani P, Nicolucci A. Misperceptions and barriers to obesity management: Italian data from the ACTION‐IO study. Eat Weight Disord. Published online May 8, 2020. doi:10.1007/s40519-020-00907-6
    1. Salvador J, Vilarrasa N, Poyato F, Rubio M. Perceptions, attitudes, and barriers to obesity management in Spain: results from the Spanish cohort of the international ACTION‐IO observation study. J Clin Med 2020;9:e2834. doi:10.3390/jcm9092834
    1. Lim S, Oh B, Lee SH, Kim YH, Ha Y, Kang JH. Perceptions, attitudes, behaviors, and barriers to effective obesity care in South Korea: results from the ACTION‐IO study. J Obes Metab Syndr 2020;29:133‐142.
    1. Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med 2020;26:485‐497.
    1. Pérez‐Salgado D, Valdés Flores J, Janssen I, Ortiz‐Hernández L. Diagnosis and treatment of obesity among Mexican adults. Obesity Facts 2012;5:937‐946.
    1. Allison DB, Downey M, Atkinson RL, et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) 2008;16:1161‐1177.
    1. Yumuk V, Tsigos C, Fried M, et al. European guidelines for obesity management in adults. Obesity Facts 2015;8:402‐424.
    1. Bleich SN, Bennett WL, Gudzune KA, Cooper LA. Impact of physician BMI on obesity care and beliefs. Obesity (Silver Spring) 2012;20:999‐1005.
    1. Berry AC, Berry NA, Myers TS, Reznicek J, Berry BB. Physician body mass index and bias toward obesity documentation patterns. Ochsner J 2018;18:66‐71.
    1. Speer SA, McPhillips R. Initiating discussions about weight in a non‐weight‐specific setting: what can we learn about the interactional consequences of different communication practices from an examination of clinical consultations? Br J Health Psychol 2018;23:888‐907.

Source: PubMed

3
Tilaa